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Objectives The objective of this prospective, single-site, 2-year dietary intervention study was to evaluate the effects of mod-
erate weight reduction and subsequent partial weight regain on cardiovascular structure and function.
Background Obesity is associated with adverse cardiac and vascular structural and functional alterations.
Methods Sixty obese subjects (age 46  10 years, body mass index 37  3 kg/m2) were evaluated during their participa-
tion in a weight loss study. Cardiac and vascular ultrasound studies were performed at baseline and at 3, 6, 12,
and 24 months after start of intervention.
Results Forty-seven subjects (78%) completed the entire 2-year follow-up. Average weight loss was 7.3  4.0%, 9.2 
5.6%, 7.8  6.6%, and 3.8  7.9% at 3, 6, 12, and 24 months, respectively. Age- and sex-adjusted mixed linear
models revealed that the follow-up time was significantly associated with decreases in weight (p  0.0001), left
ventricular (LV) mass (p  0.001), and carotid intima-media thickness (p  0.0001); there was also significant
improvement in LV diastolic (p  0.0001) and systolic (p  0.001) function. Partial weight regain diminished
the maximal observed beneficial effects of weight loss, however cardiovascular parameters measured at 2 years
still showed a net benefit compared with baseline.
Conclusions Diet-induced moderate weight loss in obese subjects is associated with beneficial changes in cardiovascular
structure and function. Subsequent weight regain is associated with partial loss of these beneficial effects.
(The Safety and Effectiveness of Low and High Carbohydrate Diets; NCT00079547) (J Am Coll Cardiol 2009;
54:2376–81) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.07.054O
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ccepted July 12, 2009.besity is associated with a 2-fold increase in the risk of
eveloping heart failure (1). Abnormalities in cardiovas-
ular structure and function that have been documented
n obesity include left ventricular hypertrophy (LVH),
eft ventricular (LV) enlargement, and LV systolic and
iastolic dysfunction, all of which are independent risk
actors for heart failure (2– 4). Weight reduction in obese
ubjects is associated with regression of these abnormal-
ties (2,5– 8). However, most studies have been confined
o class III obese subjects (body mass index [BMI] 40
g/m2) who have experienced considerable weight loss
i.e., 20% total body weight) after bariatric surgery.
Most obese persons have class I (BMI 30 to 34.9
g/m2) and class II (BMI 35 to 39.9 kg/m2) obesity
9,10). The primary therapeutic approach in these pa-
ients is to decrease caloric intake and increase caloric
xpenditure by altering lifestyle behaviors. However,
iet-induced weight loss is difficult to sustain, and many
atients who lose weight by dieting regain their lost
eight over time. The cardiovascular effects of weight
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ell-known. The purpose of this study was to prospec-
ively evaluate the effects of moderate diet-induced
eight loss (5% to 10% of body weight) and subsequent
eight regain on cardiovascular structure and function as
ssessed by cardiac and vascular ultrasound in patients
ith class I (BMI 30 to 34.9 kg/m2) and class II (BMI 35
o 39.9 kg/m2) obesity over a 2-year period.
ethods
tudy population. The study population consisted of 60
bese adults prospectively enrolled in a weight-loss study
t Washington University School of Medicine. All sub-
ects underwent a medical history, physical examination,
nd cardiovascular ultrasound. Exclusion criteria were:
ype 2 diabetes mellitus, taking weight-loss and/or lipid-
owering medications, pregnant, or lactating. The study
as approved by the Human Research Protection Office
t Washington University School of Medicine; written
nformed consent was obtained from all study participants.
tudy design. WEIGHT-LOSS INTERVENTION. Partici-
ants were randomly assigned to 1 of 2 reduced-calorie
iets for 2 years: low-fat vs. low-carbohydrate diet.
ow-carbohydrate diet subjects were instructed to limit
arbohydrate intake and to eat foods rich in fat and
rotein. Low-fat diet subjects were instructed to limit fat
ntake to approximately 30% of total calories and reduce
nergy intake (women: 1,200 to 1,500 kcal/day; men:
,500 to 1,800 kcal/day). All participants received:
) daily multivitamin supplement; 2) comprehensive
roup behavioral treatment (weekly for 20 weeks, every
ther week for 20 weeks, and every other month for the
emainder of the 2-year study) (11,12); and 3) instruc-
ions for physical activity (principally walking), beginning
t week 4 (4 sessions of 20 min each), progressing by
eek 19 to 4 sessions of 50 min each.
Body weight was measured at each treatment visit on
alibrated scales while participants wore light clothing and
o shoes. Height was measured by a stadiometer at baseline.
erial Changes in Weight and Hemodynamic Status, Plasma LipidsTable 1 Serial Changes in Weight and Hemodynamic Status, P
Baseline 3 Months
Weight, kg 104 16 96 14*
Heart rate, beats/min 73 11 68 10*
SBP, mm Hg 125 13 116 13*
DBP, mm Hg 76 9 73 8‡
Triglycerides, mmol/l 1.30 0.67 1.11 0.49‡
Total cholesterol, mmol/l 4.81 0.78 5.07 0.96‡
LDL-C, mmol/l 3.10 0.67 3.34 0.85‡
HDL-C, mmol/l 1.16 0.31 1.27 0.34*
Glucose, mmol/l 5.00 0.50 4.94 0.56
Metabolic syndrome, n (%) 26 (43) 14 (26)he p value reflects the overall adjusted model significance. Adjusted *p  0.001; †p  0.05; ‡p  0.01
DBP  diastolic blood pressure; HDL-C  high-density lipoprotein cholesterol; LDL-C  low-density lipoARDIOVASCULAR EVALUATIONS.
ardiovascular assessments were
erformed at baseline and at 3,
, 12, and 24 months after
tarting a hypocaloric diet ther-
py program. Fasting serum li-
oproteins and glucose were
ollected after a 12-h fast at
aseline and at each follow-up
isit; fasting insulin was drawn
t baseline. Heart rate and
lood pressure were assessed
ith automated instruments
Dinamap, GE Healthcare,
nited Kingdom) after 5 min
f quiet sitting, with the aver-
ge of 2 readings taken 1 min
part reported. Metabolic syn-
rome was diagnosed according
o the amended National Cho-
esterol Education Program (NCEP) Adult Treatment
anel III guidelines, except a BMI 30 kg/m2 satisfied
he criteria for increased waist circumference (13).
Complete 2-dimensional, M-mode, and Doppler echo-
ardiograms as well as carotid artery ultrasound were per-
ormed by use of commercially available ultrasound equipment
Sequoia-C256, Acuson-Siemens, Mountain View, Cal-
fornia). Two-dimensional echocardiographic measure-
ents included the LV ejection fraction calculated with
he biplane method of discs (modified Simpson’s
ethod). The LV mass was measured by the M-mode–
erived cubed method and indexed to height2.7 (LVM/
t2.7) (14). The LV geometric patterns were determined
s previously described (15). Tissue Doppler imaging
TDI)-derived myocardial systolic (S’) and early diastolic
E’) tissue velocities were obtained from the apical
-chamber view (septal and lateral velocities averaged and
eported as a global measurement) (16 –18). All measure-
ents were performed in accordance with published
uidelines and represent the average of 3 consecutive
Glucose During the StudyLipids, and Glucose During the Study
6 Months 12 Months 24 Months
94 14* 94 13* 99 15†
67 9‡ 70 8 70 9
120 12‡ 120 10* 121 13†
72 8* 74 8† 73 8‡
1.05 0.47* 1.12 0.56‡ 1.11 0.45†
4.68 0.83‡ 4.71 0.85† 4.99 0.85
3.05 0.75 2.95 0.67‡ 3.16 0.67
1.22 0.3‡ 1.24 0.28‡ 1.34 0.31*
5.00 0.61 5.05 0.50 N/A
17 (32) 12 (27) N/A
Abbreviations
and Acronyms
BMI  body mass index
CIMT  carotid intima-
media thickness
E’  early diastolic
myocardial velocity
LV  left ventricular
LVH  left ventricular
hypertrophy
LVM/Ht2.7  left
ventricular mass indexed to
height2.7
S’  systolic myocardial
velocity
SBP  systolic blood
pressure
TDI  tissue Doppler
imaging, andlasmafor the difference compared with baseline.
protein cholesterol; N/A  not available; SBP  systolic blood pressure.
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Cardiovascular Effects of Diet-Induced Weight Loss December 15/22, 2009:2376–81ardiac cycles obtained by a single observer blinded to all
linical parameters (19).
Carotid artery intima-media thickness (CIMT) was mea-
ured by a single vascular sonographer from B-mode images
f both carotid arteries expressed as the average of the far
alls of the right and left common carotid arteries; each site
epresents the average of 3 separate measurements (20). The
ntraclass correlation coefficient for repeated measures of the
IMT is 0.91 and for echocardiographic measurements
anges from 0.85 to 0.90 at our laboratory.
tatistical analysis. The SAS software (version 9.2, SAS
nstitute, Cary, North Carolina) was used for all statis-
Figure 1 Cardiovascular Structure-Function Response to Weigh
Mean ( SEM) change in (A) early diastolic myocardial velocity (E’), (B) systolic m
(D) carotid intima-media thickness in the combined cohort (blue bars) with weight
line and 3 months, 56 subjects at 6 months, and 47 subjects at 12 and 24 mont
types. *Adjusted p  0.005; †adjusted p  0.05 versus baseline.ical analyses. Chi-square analysis and Student t tests
ere performed to compare baseline values. Mixed linear
odels with repeated measures and pairwise contrasts
ere performed with a covariance structure including the
xed-effect parameters of the duration of dietary inter-
ention (i.e., follow-up time interval) for all models. All
egression models included age, sex, and dietary group as
otential covariates. Continuous variables are presented
s the mean  1 SD, except in graphics where the SEM
s shown. A p value 0.05 after adjustment for multiple
esting by the false discovery rate was considered statis-
ically significant.
s
ial velocity (S’), (C) left ventricular mass indexed to height2.7 (LVM/Ht2.7), and
e (red line) shown for reference. The combined group had 60 subjects at base-
ere was no significant difference between diet groups for any of these pheno-t Los
yocard
chang
hs. Th
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aseline characteristics. The study population consisted
f 60 obese subjects; all subjects had normal LV systolic
unction (i.e., LV ejection fraction 50%). There were no
ifferences between subjects who consumed a low-
arbohydrate versus a low-fat diet in terms of baseline
haracteristics (age, sex, racial composition, systolic and
iastolic blood pressures, serum lipids and triglycerides,
lucose, insulin, homeostasis model assessment insulin re-
istance, or percent with metabolic syndrome). Mean age
as 46  10 years, 43 (72%) were women, 15 (25%) were
frican American, BMI was 37 3 kg/m2, insulin was 13.7
9.9 U/ml, and the homeostasis model assessment
nsulin resistance was 3.1  2.5. Additional baseline char-
cteristics of the combined group are shown in Table 1.
ody weight response to diet intervention. The entire
4-month follow-up was completed by 47 subjects (78%).
here were no differences between the 2 diet groups in
erms of weight loss or any of the primary end points,
amely diet-induced changes in cardiac structure/function
nd CIMT; therefore, the data for the 2 groups were
ombined (Table 1, Fig. 1). For the entire group, average
eight loss was 7.8  4.9 kg, 9.9  6.9 kg, 8.4  7.6 kg,
nd 4.1  8.8 kg at 3, 6, 12 and 24 months, respectively,
epresenting a 7.3  4.0%, 9.2  5.6%, 7.8  6.6%, and
.8  7.9% decrease, respectively, from baseline body
eight. Maximal weight loss occurred at 6 months. Al-
hough weight regain occurred at 12 and 24 months, mean
ody weight remained lower than baseline values. Both
ietary intervention groups exhibited significant differences
etween baseline and some follow-up intervals in weight,
eart rate, systolic blood pressure, diastolic blood pressure,
nd lipid levels. Where dietary group assignment resulted in
roup differences, the low-carbohydrate diet showed differ-
nces in triglyceride and high-density lipoprotein choles-
erol levels, whereas only high-density lipoprotein choles-
erol was significantly different in the high-carbohydrate
roup. Neither group demonstrated significant changes in
lood glucose or in the percentage of subjects with meta-
olic syndrome during the follow-up interval (Table 1).
ardiovascular structure-function response to weight
oss. Compared with baseline measures, there was a signif-
cant increase (improvement) in the E’ (an index of LV
iastolic relaxation) at 6, 12, and 24 months; a significant
V Geometry and Relative Wall Thickness at Baseline and Follow-UTable 2 LV Geometry and Relative Wall Thickness at Baseline
LV Geometry,
Normal Concentric Remodeling
Baseline 31 (52) 13 (22)
3 months 35 (58) 4 (7)
6 months 35 (63) 4 (7)
12 months 29 (62) 7 (15)
24 months 26 (55) 9 (19)V  left ventricular; LVH  left ventricular hypertrophy.ecrease (improvement) in LVM/Ht2.7 at 3, 6, and 12
onths; and a significant decrease (improvement) in CIMT
t 6, 12, and 24 months (Fig. 1). Age- and sex-adjusted
ixed linear models revealed that follow-up time was
ignificantly associated with decreases in weight (F 42.51,
 0.0001), E’ (F  8.71, p  0.0001), LV mass (F 
.27, p  0.004), and CIMT (F  10.18, p  0.0001).
here was a modest increase (improvement) in S’ (an index
f LV contractile performance) at 24 months (F  5.21,
 0.001). Further post-hoc analyses divided the cohort
nto 2 equal groups by the median of S’ at baseline. In the
aseline S’ 8.0-cm/s group, a significant improvement in
’ was noted at 3, 6, 12, and 24 months compared with
aseline (F  16.75, p  0.0001); there were no significant
ifferences over time in the baseline S’ 8.0-cm/s group.
hanges in LV geometric patterns. At baseline, a major-
ty (52%) exhibited normal geometry (Table 2), whereas at
months, the proportions with normal geometry and
ccentric LVH both increased, and the proportion with
oncentric remodeling and concentric LVH decreased. Fur-
her analyses show that the changes in LV geometry are
elated to the percentage of subjects with increased relative
all thickness (adjusted p value  0.03); these findings are
onsistent with decreased LVM/Ht2.7 at 3, 6, and 12
onths.
iscussion
he results of this 2-year study demonstrate that weight loss
ntervention was associated with beneficial changes in car-
iovascular structure and function, manifested by decreased
V mass, improved diastolic and systolic function, and
ecreased vascular hypertrophy. Whereas maximal weight
oss occurred at 6 months, the maximal cardiovascular
enefits “lagged” behind the maximal weight loss by 3 to 12
onths for all measured variables. Subsequent weight re-
ain, which occurred by 6 to 12 months, was paralleled by
orsening of LV mass, diastolic function, and vascular
ypertrophy.
Abnormalities in cardiovascular structure-function in
besity have been well-characterized and include increased
lood pressures, increased LV volumes, LV hypertrophy,
ncreased wall stress, and systolic and/or diastolic dysfunc-
ion (2–8). Data from previous studies have shown that
bese subjects undergoing a combined exercise-hypocaloric
ollow-Up
Relative Wall Thickness
>0.45, n (%)ncentric LVH Eccentric LVH
12 (20) 4 (7) 25 (42)
7 (12) 14 (23) 11 (18)
6 (11) 11 (20) 10 (18)
4 (9) 7 (15) 11 (23)
6 (13) 6 (13) 15 (32)pand F
n (%)
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Cardiovascular Effects of Diet-Induced Weight Loss December 15/22, 2009:2376–81eight management program experience modest weight loss
hat is associated with lower blood pressure and with
eneficial changes in cardiac structure (i.e., decreased rela-
ive wall thickness and LVH) at 6 and 12 months (6,7).
owever, the current study extends these finding by show-
ng that changes in LV structure and function are not only
ustained at 24 months after the start of the intervention but
lso associated with improvement in LV diastolic function
nd CIMT. It is reasonable to assume that improvement of
hese adverse cardiovascular imaging biomarkers with
eight loss intervention would result in a risk reduction
ompared with those who remain obese (21,22). Studies
onducted in morbidly obese individuals have shown that
rofound weight reduction after bariatric surgery (i.e.,
20% loss from initial body weight) results in regression
f LV hypertrophy and improved systolic function
2,4,22–24).
The present study shows that obese subjects exhibit
ild alterations in cardiovascular structure and function.
here are major implications of the present study. First,
he modest observed weight loss (i.e., approximately 10%
f initial body weight) represents a realistic and attainable
oal for most obese individuals. Second, improvement in
ardiovascular structure-function parameters occur rela-
ively early (i.e., at 3 to 12 months) during modest weight
oss and most persist for the entire 24-month follow-up
eriod, thus implying that obesity-related cardiovascular
tructural-functional abnormalities are reversible. Third,
artial weight regain diminished the maximal observed
eneficial effects of weight loss in the cardiovascular
ystem. Further studies are necessary to better define the
echanisms responsible for the improvement in cardiac
nd vascular structure and function observed in this
tudy. Possible mechanisms include an improvement in
lood pressure, reduction of insulin resistance, alterations
n myocardial substrate metabolism, and/or reduction in
nflammatory cytokines (18,25–31). The results of the
resent study are interpreted in the context of a recent,
arge, 2-year trial that found that the magnitude of
eight loss was related to overall caloric intake, indepen-
ent of the different diet macronutrient composition
32). Thus, taken together, the findings of these 2 studies
uggest that the beneficial effects on the cardiovascular
ystem are related to the weight loss independent of the
acronutrient composition of the diet.
tudy limitations. Although subjects were encouraged to
ncrease their physical activity, a structured, monitored
xercise program was not part of the study; thus, it is
ossible that increased physical activity contributed to the
eneficial effects observed.
onclusions
oderate weight loss leads to early improvement of
ardiovascular structural-functional abnormalities. Al-
hough partial weight regain diminished the maximalbserved beneficial effects of weight loss, cardiovascular
arameters measured at 2 years still showed a net benefit
ompared with baseline. Whether the salutary effects of
eight loss on cardiovascular structure-function observed
n this study translate into improved clinical outcomes
equires further investigation.
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